UK drugmaker to acquire US biotech specialising in rare disease treatment
Home/FT/AstraZeneca to buy Alexion in $39bn immunology deal FT AstraZeneca to buy Alexion in $39bn immunology deal Financial Times0 Less than a minute Facebook X LinkedIn UK drugmaker to acquire US biotech specialising in rare disease treatment Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on WhatsApp (Opens in new window)Click to email a link to a friend (Opens in new window) Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print
